The Effect of 40-Hz Light Therapy on Amyloid Load in Patients with Prodromal and Clinical Alzheimer’s Disease
Open Access
- 30 July 2018
- journal article
- research article
- Published by Wiley in International Journal of Alzheimer's Disease
- Vol. 2018, 1-5
Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder. AD pathology is characterized by abnormal aggregation of the proteins amyloid-β (Aβ) and hyperphosphorylated tau. No effective disease modifying therapies are currently available. A short-duration intervention with 40 Hz light flicker has been shown to reduce brain Aβ load in transgenic mice. We aimed to test the effect of a similar short-duration 40 Hz light flicker regime in human AD patients. We utilized a Light Emitting Diode (LED) light bulb with a 40 Hz flicker. Six Aβ positive patients received 10 days of light therapy, had 2 hours of daily exposure, and underwent a postintervention PiB PET on day 11. After 10 days of light therapy, no significant decrease of PiB SUVR values was detected in any volumes of interest tested (primary visual cortex, visual association cortex, lateral parietal cortex, precuneus, and posterior cingulate) or in the total motor cortex, and longer treatments may be necessary to induce amyloid removal in humans.Keywords
Funding Information
- Lundbeck Foundation and the Department of Nuclear Medicine & PET Centre, Aarhus University Hospital
This publication has 14 references indexed in Scilit:
- Early and protective microglial activation in Alzheimer’s disease: a prospective study using18F-DPA-714 PET imagingBrain, 2016
- Neuroinflammation in Alzheimer's diseaseThe Lancet Neurology, 2015
- Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning dataEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- Amyloid, hypometabolism, and cognition in Alzheimer diseaseNeurology, 2007
- Two-year follow-up of amyloid deposition in patients with Alzheimer's diseaseBrain, 2006
- Neuropathology and Pathogenesis of Encephalitis Following Amyloid-β Immunization in Alzheimer's DiseaseYearbook of Pathology and Laboratory Medicine, 2006
- Mild cognitive impairment as a diagnostic entityJournal of Internal Medicine, 2004
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Three‐dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobeHuman Brain Mapping, 2003
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991